Status:
COMPLETED
Cancer Pain Single Nucleotide Polymorphisms (SNPs)
Lead Sponsor:
Erasmus Medical Center
Conditions:
Cancer
Pain
Eligibility:
All Genders
18+ years
Brief Summary
Cancer pain is common in advanced cancer patients. Opioids are the mainstay of treatment in cancer pain. Responsiveness to and tolerability of opioids is, amongst others, determined by small variation...
Eligibility Criteria
Inclusion
- Cancer pain patients
Exclusion
- Patients not able to provide informed consent
Key Trial Info
Start Date :
September 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
243 Patients enrolled
Trial Details
Trial ID
NCT00956878
Start Date
September 1 2008
End Date
December 1 2012
Last Update
December 24 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erasmus MC, Centrumlocatie en Daniel den Hoed
Rotterdam, South Holland, Netherlands, 3000CA